159
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Formulation, development, and in-vitro/ex-vivo evaluation of vaginal bioadhesive salbutamol sulfate tablets for preterm labor

, , &
Pages 989-998 | Received 14 Nov 2019, Accepted 06 May 2020, Published online: 23 May 2020

References

  • Abd El Azim H, Nafee N, Ramadan A, Khalafallah N. 2015. Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins. Int J Pharm. 488(1–2):78–85.
  • Alexander NJ, Baker E, Kaptein M, Karck U, Miller L, Zampaglione E. 2004. Why consider vaginal drug administration? Fertil Steril. 82(1):1–12.
  • Annadurai G, Ling LY, Lee JF. 2008. Statistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putida. J Hazard Mater. 151(1):171–178.
  • Bassi P, Kaur G. 2017. Polymeric films as a promising carrier for bioadhesive drug delivery: development, characterization and optimization. Saudi Pharm J. 25(1):32–43.
  • Berginc K, Škalko-Basnet N, Basnet P, Kristl A. 2012. Development and evaluation of an in vitro vaginal model for assessment of drug’s biopharmaceutical properties: curcumin. AAPS PharmSciTech. 13(4):1045–1053.
  • Brannon-Peppas L. 1993. Novel vaginal drug release applications. Adv Drug Deliv Rev. 11(1–2):169–177.
  • Ceschel C, Maffei P, Lombardi Borgia S, Ronchi C. 2001. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv. 8(3):161–171.
  • Desai KGH, Kumar T. 2004. Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech. 5(3):1–9.
  • Dharamsingh A, Kumar D, Mangilal T, Shyamsunder R, Jayaprakash D, Ravindranath A. 2015. Formulation and evaluation of bilayer buccal tablets of salbutamol sulphate using a combination of polymers. World J Pharm Res. 4(9):1565–1584.
  • Doelker E. 1990. Swelling behavior of water-soluble cellulose derivatives. Absorb Polym Technol. 8:125–145.
  • Elsamaligy S, Aleanizy FS, Mahmoud HA, Bayomi MA, Fitaihi RA. 2018. Role of chitosan on controlling the characteristics and antifungal activity of bioadhesive fluconazole vaginal tablets. Saudi Pharm J. 26(2):151–161.
  • Elsayed I, Abdelbary AA, Elshafeey AH. 2014. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. Int J Nanomed. 9(1):2943–2953.
  • Elzahraa F, Elsayed I, Kamal M, Hassen A, Ibrahim M. 2017. Response surface optimization, ex vivo and in vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Int J Pharm. 530(1–2):1–11.
  • Giusto K, Patki M, Koya J, Ashby CR, Munnangi S, Patel K, Reznik SE. 2019. A vaginal nanoformulation of a SphK inhibitor attenuates lipopolysaccharide-induced preterm birth in mice. Nanomedicine (Lond). 14(21):2835–2851.
  • Hani U, Krishna G, Shivakumar HG. 2015. Design and optimization of clotrimazole-hydroxypropyl-β-cyclodextrin bioadhesive vaginal tablets using Anacardium occidentale gum by 32 factorial design. RSC Adv. 5(45):35391–35404.
  • Hiorth M, Nilsen S, Tho I. 2014. Bioadhesive mini-tablets for vaginal drug delivery. Pharmaceutics. 6(3):494–511.
  • Hoang T, Zierden H, Date A, Ortiz J, Gumber S, Anders N, He P, Segars J, Hanes J, Mahendroo M, et al. 2019. Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth. J Control Release. 295:74–86.
  • Ikinci G, Senel S, Wilson CG, Sumnu M. 2004. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. Int J Pharm. 277(1–2):173–178.
  • Kassem MAA, Elmeshad AN, Fares AR. 2014. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation. Int J Pharm. 463(1):68–80.
  • Khobragade DS, Parshuramkar P, Anusha V, Potbhare M, Patil AT, Khobragade DS. 2015. Pharmaceutical evaluation of effects of hydrophilicity and hydrophobicity of three commonly used diluents on tablet formulation-part II: SR tablets. Int J Pharm Chem. 5(3):93–103.
  • Krishnamoorthy V, Priya Ranjan Prasad V, Sen S. 2013. Studies on clozapine-mannitol solid dispersions, physico chemical characterization and evaluation. Turk J Pharm Sci. 10(1):109–124.
  • Langer RS, Peppas NA. 1981. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials. 2(4):201–214.
  • Lawn JE, Cousens S, Zupan J. 2000. Neonatal survival 14 million neonatal deaths: when ? Where? Why? 9–18.
  • Lawn JE, the Born Too Soon Preterm Birth Action Group (see acknowledgement for full list), Kinney MV, Belizan JM, Mason EM, McDougall L, Larson J, Lackritz E, Friberg IK, Howson CP. 2013. Born too soon: accelerating actions for prevention and care of 15 million newborns born too soon. Reprod Health. 10(S1):1–20.
  • Lennard M. 2004. Clarke’s analysis of drugs and poisons. Br J Clin Pharmacol. 58(1):99–99.
  • Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. 2003. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int J Pharm. 253(1–2):13–22.
  • Liew CV, Chan LW, Ching AL, Heng P. 2006. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm. 309(1–2):25–37.
  • Lima JA, De Paines TC, Motta MH, Weber WB, Santos SS, Cruz L, Silva C. 2017. Novel pemulen/ pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules: evaluation of mucoadhesion and vaginal permeation. Mater Sci Eng C Mater Biol Appl. 79:886–893.
  • Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, et al. 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 379(9832):2151–2161.
  • MacDorman MF, Mathews TJ. 2009. The challenge of infant mortality: have we reached a plateau? Public Health Rep. 124(5):670–681.
  • Mahmoud D, Shukr MH, ElMeshad AN. 2018. Gastroretentive microsponge as a promising tool for prolonging the release of mitiglinide calcium in type-2 diabetes mellitus: optimization and pharmacokinetics study. AAPS PharmSciTech. 19(6):2519–2532.
  • Khan GM, Zhu JB. 1999. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. J Control Release. 57(2):197–203.
  • On R, Status A. 2013. Mucoadhesive vaginal drug delivery system: a review on advance status. Int J Pharm Res Anal. 3(1):33–46.
  • Owen DH, Katz DF. 1999. A vaginal fluid simulant. Contraception. 59(2):91–95.
  • Patel VM, Prajapati BG, Patel MM. 2007. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech. 8(1):22–E154.
  • Perioli L, Pagano C, Mazzitelli S, Rossi C, Nastruzzi C. 2008. Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration. Int J Pharm. 356(1–2):19–28.
  • Prasanna R, Chetty C, Anitha P. 2011. Formulation and evaluation of bucco-adhesive tablets of sumatriptan succinate. Int J Pharm Investig. 1(3):182–191.
  • Prasanth VV, Akashmoy C, Sam TM, Parthasarathy G, Rinku M, Sowmya TC. 2011. Formulation and evaluation of salbutamol sulphate – alginate microspheres by ionotropic gelation method. Int J Comprehens Pharm. 2(07):3–6.
  • Richardson JC, Dettmar PW, Hampson FC, Melia CD. 2005. Oesophageal bioadhesion of sodium alginate suspensions 2. Suspension behaviour on oesophageal mucosa. Eur J Pharm Sci. 24(1):107–114.
  • Ritger PL, Peppas NA. 1987. A simple equation for description of solute release II fickian and anomalous release from swellable devices. J Control Release. 5(1):37–42.
  • Roberts D, Brown J, Medley N, Dalziel SR. 2017. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017(3):CD004454. DOI:10.1002/14651858.CD004454.pub3
  • Rossi S, Bonferoni MC, Ferrari F, Caramella C. 1999. Drug release and washability of mucoadhesive gels based on sodium carboxymethylcellulose and polyacrylic acid. Pharm Sci Technol Today. 4(1):55–63.
  • Srikrishna S, Cardozo L. 2013. The vagina as a route for drug delivery: a review. Int Urogynecol J. 24(4):537–543.
  • Streubel A, Siepmann J, Bodmeier R. 2003. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci. 18(1):37–45.
  • Szymańska E, Winnicka K, Amelian A, Cwalina U. 2014. Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine. Chem Pharm Bull. 62(2):160–167.
  • United States Pharmacopeia, National Formulary. 2019. 2019 USP 42 NF 37(Vol. 4).
  • Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. 1999. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release. 57(1):75–85.
  • Warren MP. 2018. Vaginal progesterone and the vaginal first-pass effect. Climacteric. 21(4):355–357.
  • Zulfiqar B, Iftikhar R. 2016. Oral nifedipine versus intravenous salbutamol in preterm labour. Isra Med J. 8(1):3–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.